Canagliflozin Medications

Canagliflozin Info

What is Canagliflozin?

Canagliflozin belongs to a class of medicines called sodium-glucose co-transporter-2 (SGLT2) inhibitors. It helps lower blood sugar by encouraging the kidneys to remove excess glucose through the urine. In Hong Kong, canagliflozin is available in several strengths and is used for managing chronic conditions such as type 2 diabetes. The ingredient is most commonly found in the product Invokana.

Medications with Canagliflozin

The brand name Invokana (canagliflozin) is the primary medication that contains this active ingredient in Hong Kong. It is supplied as oral tablets in strengths such as 100 mg and 300 mg. Generic versions of canagliflozin may also be dispensed, usually identified simply as “canagliflozin tablets.” Both the brand and generic forms are taken by mouth and come in blister packs that protect the tablets from moisture. Availability is regulated by the Hong Kong Department of Health, and prescriptions are required for all strengths.

What Does Canagliflozin Treat?

• Type 2 diabetes mellitus - Canagliflozin helps reduce elevated blood glucose when used together with diet, exercise, and other diabetes medicines.
• Heart failure with reduced ejection fraction - In certain patients, the drug has been shown to lower the risk of hospitalization for heart failure.
• Chronic kidney disease - It can slow the decline of kidney function in adults with diabetes-related kidney problems.

These uses are approved by Hong Kong health authorities and reflect the drug’s ability to remove excess glucose and reduce the workload on the heart and kidneys.

How Canagliflozin Works

Canagliflozin blocks the SGLT2 protein in the kidneys, which normally re-absorbs glucose back into the bloodstream. By inhibiting this transporter, the medication lets more glucose be expelled in the urine, which gently lowers blood sugar levels. The effect begins within a few days of starting treatment, although full benefits for heart and kidney health may become evident over several weeks to months.

Safety Information

Common Side Effects

• Increased urination and a mild feeling of thirst are frequently reported.
• Small amounts of vaginal or genital irritation may occur due to higher glucose levels in the urine.
• Light-headedness or dizziness can happen, especially when standing up quickly.

These effects are usually temporary and lessen as the body adjusts.

Serious Reactions

• Signs of a severe allergic reaction include swelling of the face, lips, or tongue, and difficulty breathing.
• Unexplained fever, persistent nausea, vomiting, or abdominal pain may indicate a more serious condition.
• If you notice sudden changes in vision or severe tiredness, seek immediate medical attention.

Who Should Be Cautious

• People with a history of recurrent urinary or genital infections should discuss the risks with a pharmacist.
• Those with severe kidney impairment may need to avoid canagliflozin.
• Pregnant or breastfeeding individuals are generally advised not to use this medication unless clearly indicated by a healthcare professional.

Interaction Awareness

• Certain medicines, such as diuretics or other glucose-lowering agents, can increase the chance of low blood pressure or low blood sugar when taken together with canagliflozin.
• Alcohol can raise the risk of dehydration and dizziness, so moderation is advisable.
• A high-salt diet may counteract some of the blood-pressure-lowering benefits of the drug.

For a complete list of interactions, refer to the specific product’s information sheet.

What to Know Before Using

Store tablets in a dry place away from direct sunlight and keep them out of reach of children. Typical treatment courses range from short-term use for sudden blood-sugar spikes to long-term management of diabetes and related heart or kidney conditions. Because each brand or generic formulation can differ in strength, always follow the instructions that accompany your particular medication.

Key Terms

SGLT2 inhibitor: A type of medication that blocks the kidney’s sodium-glucose co-transporter-2, helping the body eliminate excess glucose through urine.

eGFR: Estimated glomerular filtration rate, a measure of kidney function that helps determine whether canagliflozin is appropriate.

Genital mycotic infection: A fungal infection in the genital area, sometimes seen when glucose levels in urine rise.

Important Notice

This article offers general educational information about canagliflozin as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing canagliflozin may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.